NZ509593A - Compressed compositions comprising clarified xanthan gum - Google Patents
Compressed compositions comprising clarified xanthan gumInfo
- Publication number
- NZ509593A NZ509593A NZ509593A NZ50959399A NZ509593A NZ 509593 A NZ509593 A NZ 509593A NZ 509593 A NZ509593 A NZ 509593A NZ 50959399 A NZ50959399 A NZ 50959399A NZ 509593 A NZ509593 A NZ 509593A
- Authority
- NZ
- New Zealand
- Prior art keywords
- xanthan gum
- clarified xanthan
- compressed compositions
- sustained release
- clarified
- Prior art date
Links
- 229920001285 xanthan gum Polymers 0.000 title abstract 5
- 229940082509 xanthan gum Drugs 0.000 title abstract 5
- 235000010493 xanthan gum Nutrition 0.000 title abstract 5
- 239000000230 xanthan gum Substances 0.000 title abstract 5
- 239000000203 mixture Substances 0.000 title abstract 2
- 238000013268 sustained release Methods 0.000 abstract 2
- 239000012730 sustained-release form Substances 0.000 abstract 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 2
- 238000004090 dissolution Methods 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000002831 pharmacologic agent Substances 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
- 238000002834 transmittance Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9816723.2A GB9816723D0 (en) | 1998-08-01 | 1998-08-01 | Therapeutic agents |
| PCT/EP1999/005499 WO2000007569A1 (en) | 1998-08-01 | 1999-07-28 | Compressed compositions comprising clarified xanthan gum |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ509593A true NZ509593A (en) | 2002-12-20 |
Family
ID=10836508
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ509593A NZ509593A (en) | 1998-08-01 | 1999-07-28 | Compressed compositions comprising clarified xanthan gum |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP1100471B1 (https=) |
| JP (1) | JP2002522376A (https=) |
| CN (1) | CN1160060C (https=) |
| AR (1) | AR019981A1 (https=) |
| AT (1) | ATE249815T1 (https=) |
| AU (1) | AU744483B2 (https=) |
| CA (1) | CA2339190C (https=) |
| DE (1) | DE69911427T2 (https=) |
| DK (1) | DK1100471T3 (https=) |
| ES (1) | ES2207274T3 (https=) |
| GB (1) | GB9816723D0 (https=) |
| MX (1) | MXPA01000992A (https=) |
| NZ (1) | NZ509593A (https=) |
| PT (1) | PT1100471E (https=) |
| WO (1) | WO2000007569A1 (https=) |
| ZA (1) | ZA200100828B (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1610551A (zh) | 2001-07-06 | 2005-04-27 | 恩德制药公司 | 用作止痛剂的6－羟基羟吗啡酮的肠胃外给药 |
| AU2002337686B2 (en) * | 2001-09-26 | 2008-05-15 | Penwest Pharmaceuticals Company | Opioid formulations having reduced potential for abuse |
| CN117752805B (zh) * | 2023-12-25 | 2024-12-24 | 山东聊城阿华制药股份有限公司 | 一种药用辅料及其制备方法 |
| KR102881485B1 (ko) * | 2024-03-22 | 2025-11-05 | (주) 팜젠사이언스 | 천연첨가제에 기반한 비타민c 조성물 및 이를 포함하는 지속성 비타민c 정제 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4135979A (en) * | 1976-08-24 | 1979-01-23 | Merck & Co., Inc. | Treatment of xanthan gum to improve clarity |
| GB8601204D0 (en) * | 1986-01-18 | 1986-02-19 | Boots Co Plc | Therapeutic agents |
| US4915948A (en) * | 1987-08-31 | 1990-04-10 | Warner-Lambert Company | Tablets having improved bioadhesion to mucous membranes |
| CA2017249C (en) * | 1989-05-24 | 2000-07-25 | Theresa M. Ortega | Rheology controlled fabric printing composition and method |
-
1998
- 1998-08-01 GB GBGB9816723.2A patent/GB9816723D0/en not_active Ceased
-
1999
- 1999-07-28 AT AT99941487T patent/ATE249815T1/de not_active IP Right Cessation
- 1999-07-28 AU AU55087/99A patent/AU744483B2/en not_active Ceased
- 1999-07-28 CN CNB998113735A patent/CN1160060C/zh not_active Expired - Fee Related
- 1999-07-28 WO PCT/EP1999/005499 patent/WO2000007569A1/en not_active Ceased
- 1999-07-28 NZ NZ509593A patent/NZ509593A/xx unknown
- 1999-07-28 DE DE69911427T patent/DE69911427T2/de not_active Expired - Fee Related
- 1999-07-28 JP JP2000563255A patent/JP2002522376A/ja active Pending
- 1999-07-28 EP EP99941487A patent/EP1100471B1/en not_active Expired - Lifetime
- 1999-07-28 MX MXPA01000992A patent/MXPA01000992A/es unknown
- 1999-07-28 PT PT99941487T patent/PT1100471E/pt unknown
- 1999-07-28 DK DK99941487T patent/DK1100471T3/da active
- 1999-07-28 ES ES99941487T patent/ES2207274T3/es not_active Expired - Lifetime
- 1999-07-28 CA CA002339190A patent/CA2339190C/en not_active Expired - Fee Related
- 1999-07-30 AR ARP990103817A patent/AR019981A1/es unknown
-
2001
- 2001-01-30 ZA ZA200100828A patent/ZA200100828B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DK1100471T3 (da) | 2004-01-12 |
| CN1160060C (zh) | 2004-08-04 |
| CA2339190C (en) | 2008-11-18 |
| CN1354653A (zh) | 2002-06-19 |
| ES2207274T3 (es) | 2004-05-16 |
| ATE249815T1 (de) | 2003-10-15 |
| DE69911427T2 (de) | 2004-07-01 |
| DE69911427D1 (de) | 2003-10-23 |
| EP1100471A1 (en) | 2001-05-23 |
| EP1100471B1 (en) | 2003-09-17 |
| AR019981A1 (es) | 2002-03-27 |
| ZA200100828B (en) | 2001-10-22 |
| MXPA01000992A (es) | 2002-06-04 |
| AU5508799A (en) | 2000-02-28 |
| JP2002522376A (ja) | 2002-07-23 |
| CA2339190A1 (en) | 2000-02-17 |
| AU744483B2 (en) | 2002-02-28 |
| PT1100471E (pt) | 2003-12-31 |
| GB9816723D0 (en) | 1998-09-30 |
| WO2000007569A1 (en) | 2000-02-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IE863420L (en) | Xanthan gum sustained drug release composition | |
| IL111647A0 (en) | Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles, their preparation and pharmaceutical compositions containing them | |
| ATE234634T1 (de) | Feste pharmazeutische formulierungen enthaltend eine physische mischung aus sulphoalkylethercyclodextrin und einem therapeutischen wirkstoff | |
| ES2185179T3 (es) | Preparacion de composiciones farmaceuticas. | |
| GB9901819D0 (en) | Pharmaceutical compositions | |
| DE59708148D1 (de) | Kosmetisches präparat mit peptidzusatz | |
| YU49698A (sh) | Smeše koje sadrže tetrahidrolipstatin | |
| IL117356A (en) | Controlled release matrix and pharmaceutical compositions for oral administration containing it | |
| CA2203033A1 (en) | Compounds and compositions for delivering active agents | |
| GB9401892D0 (en) | Therapeutic agents | |
| TNSN97114A1 (fr) | Granule pour la preparation des compositions a desintegration et dissolution rapides comprenant une teneur elevee d'un principe actif | |
| EP1137403A4 (en) | A HYDROCOLLOID AND A DELIVERY-RELATED TABLET CONTAINING CELLULOSE ETHER | |
| RU94046044A (ru) | Новые 7 бета -замещенные 4-аза- 5 альфа -холестан-оны в качестве ингибиторов 5 альфа -редуктазы, фармацевтическая композиция на их основе, способ ее получения | |
| NO944113D0 (no) | Stabilt, hydratisert cefalosporin-tört pulver for oral suspensjonsformulering | |
| PT615754E (pt) | Formas solidas de administracao oral de libertacao controlada flupertina | |
| NZ337418A (en) | Paracetamol composition with improved rate of absorption | |
| AR018607A1 (es) | Preparacion farmaceutica que en calidad de ingrediente activo contiene levotiroxina sodica, y un procedimiento para su preparacion | |
| BG105570A (en) | Pharmaceutical compositions for modified release insulin sensitiser | |
| FR2712809B1 (fr) | Nouvelle composition pharmaceutique destinée à la préparation d'une poudre stable contenant, à titre d'ingrédient actif, une association d'acide acétylsalicylique et de métoclopramide. | |
| NZ509593A (en) | Compressed compositions comprising clarified xanthan gum | |
| CA2103725A1 (en) | Composition for use in transdermal administration | |
| WO2003061557A3 (en) | Levothyroxine pharmaceutical compositions, methods of making and methods of administration | |
| IL110471A0 (en) | Oral water soluble pharmaceutical compositions containing estrone derivative | |
| SE8703889L (sv) | Farmaceutiska kompositioner med fordrojd frigoring | |
| DE69830078D1 (de) | Suesstoffzusammensetzung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PSEA | Patent sealed | ||
| RENW | Renewal (renewal fees accepted) |